Intellectual property
The technology is protected by a granted French patent.
Stimly develops patented non-invasive neurostimulation technology.
A wearable device worn at the wrist, developed and patented in France.
What it's for
A wearable neurostimulation device
Stimly explores the use of wrist-worn neurostimulation as support for smoking cessation. Two usage modes are offered: short on-demand sessions, and longer sessions.
Technology
How it works
The device delivers transcutaneous electrical neurostimulation through the skin at the wrist. It runs two programs — a short on-demand mode and a longer mode — and is rechargeable, with user-controlled intensity. It uses two types of electrodes depending on the mode: metal contact surfaces integrated into the housing for short on-demand sessions, and a soft conductive gel pad for long sessions.
- Signal
- Biphasic symmetric
- Intensity
- Adjustable (user-controlled)
- Current
- Low-intensity
- Power
- Rechargeable
LED dots
intensity level
Session mode
long or short
Research & Development
Intellectual property and clinical feasibility
Clinical feasibility
A feasibility study was conducted under the French RIPH framework, with regulatory and data-protection approvals.
Company
About Stimly
Founded in 2019 and based in Paris, Stimly focuses on non-medicated, non-invasive approaches to wellbeing and smoking cessation support.
Contact
Get in touch
For any inquiry, get in touch.